Issued Patents All Time
Showing 26–50 of 50 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10293027 | Methods for treating metabolic disorders using FGF | Johan W. Jonker, Ronald M. Evans, Jae Myoung Suh | 2019-05-21 |
| 10238667 | Vitamin D receptor/SMAD genomic circuit gates fibrotic response | Ning Ding, Christopher Liddle, Ronald M. Evans, Nanthakumar Subramaniam | 2019-03-26 |
| 10188627 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Ronald M. Evans, Arthur F. Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi +4 more | 2019-01-29 |
| 10159711 | Methods for treating metabolic disorders using FGF | Johan W. Jonker, Ronald M. Evans, Jae Myoung Suh | 2018-12-25 |
| 10077268 | FXR agonists and methods for making and using | Ronald M. Evans, Thomas J. Baiga, John F. W. Keana, Christopher Liddle | 2018-09-18 |
| 10035819 | PPAR agonists and methods of use thereof | Ronald M. Evans | 2018-07-31 |
| 9938234 | PPAR agonists | Ronald M. Evans, Thomas J. Baiga, Joseph P. Noel, Emi Kanakubo Embler, Weiwei Fan +4 more | 2018-04-10 |
| 9925243 | Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of use | Jae Myoung Suh, Ronald M. Evans, Annette Atkins, Senyon Choe, Witek Kwiatkowski | 2018-03-27 |
| 9925241 | Mutated fibroblast growth factor (FGF) 1 and methods of use | Jae Myoung Suh, Ronald M. Evans, Annette Atkins, Ruth T. Yu | 2018-03-27 |
| 9895381 | Vitamin D receptor agonists to treat diseases involving CXCL12 activity | Mara Sherman, Ronald M. Evans | 2018-02-20 |
| 9872866 | Vitamin D receptor/SMAD genomic circuit gates fibrotic response | Ning Ding, Christopher Liddle, Ronald M. Evans | 2018-01-23 |
| 9808508 | Methods for treating metabolic disorders using FGF | Johan W. Jonker, Ronald M. Evans, Jae Myoung Suh | 2017-11-07 |
| 9546379 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Ronald M. Evans, Eiji Yoshihara, Ruth T. Yu, Annette Atkins | 2017-01-17 |
| 9446097 | Methods for treating metabolic disorders using FGF | Johan W. Jonker, Ronald M. Evans, Jae Myoung Suh | 2016-09-20 |
| 9192601 | Methods for enhancing muscle performance and tone | Ronald M. Evans, Vihang A. Narkar, Reuben J. Shaw, Ruth T. Yu | 2015-11-24 |
| 9072708 | Methods for treating metabolic disorders using FGF | Johan W. Jonker, Ronald M. Evans, Jae Myoung Suh | 2015-07-07 |
| 8999929 | Fibroblast growth factor 1 protein fragments and methods of use | Moosa Mohammadi, Regina Goetz, Ronald M. Evans, Jae Myoung Suh | 2015-04-07 |
| 8962546 | Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor | Vihang A. Narkar, Ruth T. Yu, Ronald M. Evans | 2015-02-24 |
| 8906854 | Methods for treating metabolic disorders using FGF | Johan W. Jonker, Ronald M. Evans, Jae Myoung Suh | 2014-12-09 |
| 8318708 | Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis | Ronald M. Evans, Christopher Liddle, Nanthakumar Subramaniam, Caroline Flora Samer | 2012-11-27 |
| 8212006 | Structure of the farnesoid X receptor ligand binding domain and methods of use therefor | Mark A. Verdicia, Joseph P. Noel, Ronald M. Evans, Lindsey J. Bowman, Marianne Bowman | 2012-07-03 |
| 7671085 | Non-steroidal farnesoid X receptor modulators and methods for the use thereof | Ronald M. Evans | 2010-03-02 |
| 7647217 | Structure of the farnesoid X receptor ligand binding domain and methods of use therefor | Mark A. Verdicia, Joseph P. Noel, Ronald M. Evans, Lindsey J. Bowman, Marianne Bowman | 2010-01-12 |
| 7314747 | SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors | Ronald M. Evans, J. Don Chen, Peter Ordentlich | 2008-01-01 |
| 6673587 | Histone deacetylase, and uses therefor | Ronald M. Evans, Hung-Ying Kao, Peter Ordentlich | 2004-01-06 |